EGFR and neoplasm: When metformin is used in combination with anti-tumor drugs, such as traditional chemotherapy drugs, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI), or immune checkpoint inhibitors (ICIs), it improves the anti-tumor effects of the drug (15, 16).